Discovery and Identification of Pyrazolopyramidine Analogs as Novel Potent Androgen Receptor Antagonists
Androgen receptor (AR), an important target in the current androgen derivation therapy, plays a critical role in the development and progress of prostate cancer (PCa).Nonsteroidal antiandrogens, such as enzalutamide and bicalutamide, Jumbo OFC are commonly used in clinic to treat PCa.Though they are very effective at the beginning, drug resistance